Global /Australia /Healthcare /Drug Manufacturers - Specialty & Generic /AGH

Althea Group Holdings Ltd.

AGH

• ASX: AGH • Delayed

0.0200AUD -4.8%

0.0141 USD

As of 6 June 2026, Althea Group Holdings Ltd. has a market cap of $15.01M USD, ranking #38986 globally and #1195 in Australia. It ranks #3483 in the Healthcare sector, and #229 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

38986

Country Rank

1195

Sector Rank

3483

Industry Rank

229

Key Stats

Market Cap

$15.01MUSD

21.04M AUD

Enterprise Value

$18.75MUSD

26.62M AUD

Revenue (TTM)

$11.06MUSD

15.49M AUD

EBITDA (TTM)

-$1.97MUSD

-2.79M AUD

Net Income (TTM)

-$5.96MUSD

-8.35M AUD

EBITDA Margin

-18%

Profit Margin

-54%

PS Ratio

1.4

PB Ratio

-36.7

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Barry Katzman open_in_new

Founded

2016

Website

peakprocessing.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.8%	5%	0%	-4.5%	-19%	-38%	-38%	-68%	-96%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	AGH Althea Group Holdings Ltd Ordinary Shares ISIN: AU0000022774 Shares Out.: Shares Outstanding: 1.002B¹ Shares Float: 871.896M² TV: TradingView: ASX: AGH SA: Stock Analysis: ASX: AGH YF: Yahoo Finance: AGH.AX GF: Google Finance: ASX: AGH BA: Barron's: AGH MS: Morningstar: XASX: AGH	0.0200 AUD	TV: TradingView: ASX: AGH SA: Stock Analysis: ASX: AGH YF: Yahoo Finance: AGH.AX GF: Google Finance: ASX: AGH BA: Barron's: AGH MS: Morningstar: XASX: AGH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Althea Group Holdings Ltd.

Althea Group Holdings Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. The company sells its products through retail stores. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Australia)

Name	Market Cap (USD) diff.	PE	Country
Neuren Pharmaceuticals Ltd. ASX: NEU	$1.11B 1.55B AUD 7K%	52.7	Australia
Actinogen Medical Ltd. ASX: ACW	$123.03M 172.39M AUD 719%	-	Australia
Clover Corporation Ltd. ASX: CLV	$114.37M 160.26M AUD 662%	18.1	Australia
Vita Life Sciences Ltd. ASX: VLS	$100.03M 140.17M AUD 566%	14.1	Australia
Paradigm Biopharmaceuticals Ltd. ASX: PAR	$56.42M 79.06M AUD 276%	-	Australia
Beroni Group Ltd. OTCMKTS: BNIGF	$49.41M 229%	-	Australia

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 251K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 197K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 106K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 74K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 73K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 61K%	80.6	China

chevron_leftBack